The estimated Net Worth of Gary Blackford is at least $1.34 Million dollars as of 8 May 2020. Mr. Blackford owns over 10,000 units of Wright Medical NV stock worth over $1,044,653 and over the last 9 years he sold WMGI stock worth over $0. In addition, he makes $296,465 as Non-Executive Independent Director at Wright Medical NV.
Sign up
Mr. Blackford WMGI stock SEC Form 4 insiders trading
Gary has made over 4 trades of the Wright Medical NV stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of WMGI stock worth $287,500 on 8 May 2020.
The largest trade he's ever made was buying 10,000 units of Wright Medical NV stock on 8 May 2020 worth over $287,500. On average, Gary trades about 677 units every 14 days since 2015. As of 8 May 2020 he still owns at least 34,845 units of Wright Medical NV stock.
You can see the complete history of Mr. Blackford stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Gary Blackford biography
Gary D. Blackford J.D. serves as Non-Executive Independent Director of the Company. Mr. Blackford was a member of the board of directors of Wright Medical Group, Inc. from 2008 to 2015. From 2002 to February 2015, Mr. Blackford served as President and Chief Executive Officer and a member of the board of directors of Universal Hospital Services, Inc., a provider of medical technology outsourcing and services to the healthcare industry, and from 2007 to February 2015, served as Chairman of the board of directors. From 2001 to 2002, Mr. Blackford served as Chief Executive Officer of Curative Health Services Inc. From 1999 to 2001, Mr. Blackford served as Chief Executive Officer of ShopforSchool, Inc. He served as Chief Operating Officer for Value Rx from 1995 to 1998 and Chief Operating Officer and Chief Financial Officer of MedIntel Systems Corporation from 1993 to 1994. Mr. Blackford currently serves on the board of directors of Avanos Medical, Inc. (formerly Halyard Health, Inc.) and ReShape Lifesciences Inc. (formerly EnteroMedics Inc.), both publicly held companies. He also serves on the board of directors of Pipeline Rx, Inc., a privately held telepharmacy company and is the Chairman of the Minnesota Children’s Hospitals and Clinics. Mr. Blackford previously served on the board of directors of Compex Technologies, Inc., a publicly held medical device company, from 2005 until its acquisition by Encore Medical Corporation in 2006. Mr. Blackford’s qualifications to serve as a member of our board of directors include his experience as a chief executive officer and director of a healthcare services company and other companies and as a director of other public companies in the healthcare industry, his extensive experience leading healthcare companies, and his prior experience as a director of legacy Wright.
What is the salary of Gary Blackford?
As the Non-Executive Independent Director of Wright Medical NV, the total compensation of Gary Blackford at Wright Medical NV is $296,465. There are 13 executives at Wright Medical NV getting paid more, with Robert Palmisano having the highest compensation of $7,309,180.
How old is Gary Blackford?
Gary Blackford is 63, he's been the Non-Executive Independent Director of Wright Medical NV since 2015. There are 5 older and 18 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
What's Gary Blackford's mailing address?
Gary's mailing address filed with the SEC is 1023, Cherry Road, The Village, Memphis, Shelby County, Tennessee, 38117, United States of America.
Insiders trading at Wright Medical NV
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman und Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
What does Wright Medical NV do?
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
What does Wright Medical NV's logo look like?
Complete history of Mr. Blackford stock trades at Wright Medical NV und Avanos Medical Inc
Wright Medical NV executives and stock owners
Wright Medical NV executives and other stock owners filed with the SEC include:
-
Robert Palmisano,
President and Chief Executive Officer, Executive Director -
Peter Cooke,
President, Emerging Markets, Australia and Japan -
Lance Berry,
Executive Vice President, Chief Financial and Operations Officer -
Kevin Cordell,
Executive Vice President, Chief Global Commercial Officer -
Andrew Morton,
Senior Vice President, Chief Human Resources Officer -
James Lightman,
Senior Vice President, General Counsel and Secretary -
Barry Regan,
Senior Vice President, Operations -
Jason Asper,
Senior Vice President, Chief Digital Officer -
David Stevens,
Non-Executive Independent Chairman of the Board -
Kevin O'Boyle,
Non-Executive Independent Director -
Elizabeth Weatherman,
Non-Executive Independent Director -
John Miclot,
Non-Executive Independent Director -
Richard Wallman,
Non-Executive Independent Director -
Gary Blackford,
Non-Executive Independent Director -
Amy Paul,
Non-Executive Independent Director -
James Mackin,
Non-Executive Independent Director -
Steven Wallace,
President, International -
Kevin Smith,
Senior Vice President, Quality and Regulatory -
Julie Dewey,
Senior Vice President, Chief Communications Officer -
Timothy Lanier,
President, Upper Extremities -
Patrick Fisher,
President, Lower Extremities -
Julie Andrews,
Senior Vice President, Global Finance -
Jennifer Walker,
Senior Vice President, Process Improvement -
J. Porter,
Senior Vice President, Chief Compliance Officer -
Tim Lanier,
President, Upper Extremities -
Sean Carney,
Director -
William L. Jr Griffin,
SVP GM BioMimetic Therapeutics -
Terry M. Rich,
President, Upper Extremities -
Gregory Morrison,
Sr. VP, Human Resources -
Robert P. Iii Burrows,
SVP, Supply Chain -
David H Mowry,
EVP and COO -
Ummersen Gordon Van,
Sr. VP, Product Delivery -
Holdings Cooperatief U.A.Wa...,
-
Alain Tornier,
Director -
Richard B Emmitt,
Director -
Kevin M Klemz,
Sr. VP, CLO and Secretary -
Shawn Mc Cormick,
Chief Financial Officer -
Medical Group N.V. Wright,
President, Lower Extremities